Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China flag China · Delayed Price · Currency is CNY
59.24
-0.89 (-1.48%)
Sep 9, 2026, 4:00 PM EDT

SHE:301075 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
64.9285.28262.13405.27425.76610.93
Trading Asset Securities
-20.04141.6877.5780-
Cash & Short-Term Investments
64.92105.32403.81482.84505.76610.93
Cash Growth
-80.49%-73.92%-16.37%-4.53%-17.21%484.67%
Accounts Receivable
101.3887.89107.9485.5192.3100.33
Other Receivables
16.6117.0919.5511.27.882.28
Receivables
117.99104.98127.4996.7100.18102.6
Inventory
107.8883.5445.8533.1332.779.82
Prepaid Expenses
--00.050.060.06
Other Current Assets
31.2435.2353.6136.238.665.64
Total Current Assets
322.04329.06630.75648.95647.43729.05
Property, Plant & Equipment
712.57694.53652.8209.8110.68103.41
Long-Term Investments
107.75110.99108.18155.36112.62-
Goodwill
18.6218.719.223.69--
Other Intangible Assets
95.0476.6478.4834.1921.2416.85
Long-Term Deferred Tax Assets
0.433.493.091.250.780.65
Long-Term Deferred Charges
0.362.012.842.70.331.46
Other Long-Term Assets
53.3547.839.6416.335.8-
Total Assets
1,3101,2831,5351,072898.87851.42

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
113.3677.2958.1426.7712.1323.01
Accrued Expenses
4.37.6398.5813.0910.46
Short-Term Debt
17.71229.47275.5450.13100.0620
Current Portion of Long-Term Debt
171.5108.14115.2111.01--
Current Portion of Leases
-2.223.030.60.290.48
Current Income Taxes Payable
0.51-1.262.411.352.87
Current Unearned Revenue
13.137.552.785.084.163.72
Other Current Liabilities
166.649.8444.4124.613.492.25
Total Current Liabilities
487.17442.14509.37129.18144.5762.79
Long-Term Debt
-88.5137.5118.08--
Long-Term Leases
1.783.737.210.310.88-
Long-Term Unearned Revenue
101.13105.02106.92.12--
Long-Term Deferred Tax Liabilities
20.1620.2920.540.9--
Total Liabilities
610.25659.67781.52250.59145.4562.79

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
808080808080
Additional Paid-In Capital
559.22506.89506.94509.22509.5520.5
Retained Earnings
19.27.47109.64182.17163.32192.42
Treasury Stock
--20.99-20.99---
Comprehensive Income & Other
1.141.141.140.68-1.3-
Total Common Equity
659.57574.51676.73772.06751.53792.92
Minority Interest
40.3649.0376.7449.611.89-4.28
Shareholders' Equity
699.92623.54753.47821.68753.41788.63
Total Liabilities & Equity
1,3101,2831,5351,072898.87851.42

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
190.99432.06538.5180.12101.2420.48
Net Cash (Debt)
-126.07-326.74-134.69302.72404.53590.45
Net Cash Growth
----25.17%-31.49%750.31%
Net Cash Per Share
-1.58-4.13-1.703.855.139.05
Filing Date Shares Outstanding
81.3278.9678.96808080
Total Common Shares Outstanding
81.3278.9678.96808080
Working Capital
-165.13-113.07121.38519.77502.85666.26
Book Value Per Share
8.117.288.579.659.399.91
Tangible Book Value
545.91479.17579.04734.19730.29776.06
Tangible Book Value Per Share
6.716.077.339.189.139.70
Buildings
-530.63506.96167.55117.46103.71
Machinery
-259.16251.45126.263.4760.37
Construction In Progress
-64.095.679.083.940.36